本页面由Tiger Trade Technology Pte. Ltd.提供服务

PMV Pharmaceuticals

1.32
-0.0100-0.75%
盘后1.32-0.0004-0.03%18:27 EDT
成交量:26.00万
成交额:33.95万
市值:7,023.92万
市盈率:-0.89
高:1.33
开:1.32
低:1.29
收:1.33
52周最高:1.88
52周最低:0.8100
股本:5,321.15万
流通股本:3,620.46万
量比:0.88
换手率:0.72%
股息:- -
股息率:- -
每股收益(TTM):-1.4800
每股收益(LYR):-1.4800
净资产收益率:-55.37%
总资产收益率:-35.00%
市净率:0.67
市盈率(LYR):-0.89

数据加载中...

2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/06

重要事件披露

8-K - Current report
2021/11/12

重要事件披露

8-K - Current report
2021/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/18

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/10/05

重要事件披露

8-K - Current report
2021/08/13

重要事件披露

8-K - Current report
2021/08/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/07

重要事件披露

8-K - Current report
2021/05/21

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/14

重要事件披露

8-K - Current report